Cargando…
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis
BACKGROUND: There is insufficient evidence on the clinical effectiveness and safety of infliximab (IFX) treatment of Takayasu arteritis (TA) in infants. METHODS: We evaluated the therapeutic effectiveness and safety of IFX in a retrospective case series of 10 infantile TA patients. Observations incl...
Autores principales: | Kang, Min, Lai, Jianming, Zhang, Dan, Xu, Yingjie, Zhu, Jia, Li, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351063/ https://www.ncbi.nlm.nih.gov/pubmed/35927694 http://dx.doi.org/10.1186/s12969-022-00708-4 |
Ejemplares similares
-
Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu arteritis patients: a retrospective study
por: Xu, Yingjie, et al.
Publicado: (2023) -
An Update on Childhood-Onset Takayasu Arteritis
por: Aeschlimann, Florence A., et al.
Publicado: (2022) -
Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report
por: Masui, Sho, et al.
Publicado: (2019) -
Late Onset Takayasu Arteritis and Rheumatoid Arthritis
por: Verweij, K. E., et al.
Publicado: (2012) -
Features of the Onset of Takayasu's Arteritis According to
Gender
por: Mont'Alverne, Andrea Rocha de Saboia, et al.
Publicado: (2013)